New York, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Veterinary Molecular Diagnostics Industry" - https://www.reportlinker.com/p05961214/?utm_source=GNW
3% over the analysis period 2020-2027. Instruments & Software, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$269.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 8.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $126.7 Million, While China is Forecast to Grow at 11.1% CAGR

The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$126.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$170 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Services Segment to Record 6.2% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$87 Million in the year 2020 will reach a projected size of US$128 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$105.8 Million by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 372-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,




Read the full report: https://www.reportlinker.com/p05961214/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Veterinary Molecular Diagnostics Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Veterinary
Molecular Diagnostics by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027

Table 2: World Historic Review for Veterinary Molecular
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019

Table 3: World 15-Year Perspective for Veterinary Molecular
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Instruments &
Software by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 5: World Historic Review for Instruments & Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 6: World 15-Year Perspective for Instruments & Software
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Kits & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 8: World Historic Review for Kits & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 9: World 15-Year Perspective for Kits & Reagents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Polymerase Chain
Reaction (PCR) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027

Table 14: World Historic Review for Polymerase Chain Reaction
(PCR) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 15: World 15-Year Perspective for Polymerase Chain
Reaction (PCR) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 16: World Current & Future Analysis for Microarrays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 17: World Historic Review for Microarrays by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 18: World 15-Year Perspective for Microarrays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for DNA Sequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 20: World Historic Review for DNA Sequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 21: World 15-Year Perspective for DNA Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hospitals/Clinics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 23: World Historic Review for Hospitals/Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 24: World 15-Year Perspective for Hospitals/Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Reference
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027

Table 26: World Historic Review for Reference Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 27: World 15-Year Perspective for Reference Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Veterinary Molecular Diagnostics Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 28: USA Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 29: USA Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 30: USA 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 32: USA Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 33: USA 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 35: USA Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 36: USA 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 38: Canada Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 39: Canada 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 41: Canada Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 42: Canada 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 44: Canada Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 45: Canada 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 47: Japan Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 48: Japan 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 50: Japan Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 51: Japan 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 53: Japan Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 54: Japan 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 56: China Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 57: China 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 59: China Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 60: China 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 62: China Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 63: China 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Veterinary Molecular Diagnostics Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 64: Europe Current & Future Analysis for Veterinary
Molecular Diagnostics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 65: Europe Historic Review for Veterinary Molecular
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 66: Europe 15-Year Perspective for Veterinary Molecular
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 68: Europe Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 69: Europe 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 71: Europe Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 72: Europe 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 74: Europe Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 75: Europe 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 77: France Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 78: France 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 80: France Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 81: France 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 83: France Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 84: France 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 86: Germany Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 87: Germany 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 89: Germany Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 90: Germany 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 92: Germany Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 93: Germany 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 95: Italy Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 96: Italy 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 98: Italy Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 99: Italy 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 101: Italy Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 102: Italy 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 104: UK Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 105: UK 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 107: UK Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 108: UK 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 110: UK Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 111: UK 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

SPAIN
Table 112: Spain Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 113: Spain Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 114: Spain 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 115: Spain Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 116: Spain Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 117: Spain 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 118: Spain Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 119: Spain Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 120: Spain 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

RUSSIA
Table 121: Russia Current & Future Analysis for Veterinary
Molecular Diagnostics by Product Segment - Instruments &
Software, Kits & Reagents and Services - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 122: Russia Historic Review for Veterinary Molecular
Diagnostics by Product Segment - Instruments & Software, Kits &
Reagents and Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019

Table 123: Russia 15-Year Perspective for Veterinary Molecular
Diagnostics by Product Segment - Percentage Breakdown of Value
Sales for Instruments & Software, Kits & Reagents and Services
for the Years 2012, 2020 & 2027

Table 124: Russia Current & Future Analysis for Veterinary
Molecular Diagnostics by Technology Type - Polymerase Chain
Reaction (PCR), Microarrays and DNA Sequencing - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 125: Russia Historic Review for Veterinary Molecular
Diagnostics by Technology Type - Polymerase Chain Reaction
(PCR), Microarrays and DNA Sequencing Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 126: Russia 15-Year Perspective for Veterinary Molecular
Diagnostics by Technology Type - Percentage Breakdown of Value
Sales for Polymerase Chain Reaction (PCR), Microarrays and DNA
Sequencing for the Years 2012, 2020 & 2027

Table 127: Russia Current & Future Analysis for Veterinary
Molecular Diagnostics by End-Use - Hospitals/Clinics and
Reference Laboratories - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027

Table 128: Russia Historic Review for Veterinary Molecular
Diagnostics by End-Use - Hospitals/Clinics and Reference
Laboratories Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 129: Russia 15-Year Perspective for Veterinary Molecular
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals/Clinics and Reference Laboratories for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 130: Rest of Europe Current & Future Analysis for
Veterinary Molecular Diagnostics by Product Segment -
Instruments & Software, Kits & Reagents and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 131: Rest of Europe Historic Review for Veterinary

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05961214/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001